This Article Full Text (PDF) All Versions of this Article: 1087057108323909v1 13/9/870    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Seyb, K.I. Articles by Glicksman, M.A. Search for Related Content PubMed PubMed Citation Articles by Seyb, K.I. Articles by Glicksman, M.A. Social Bookmarking                   What's this?

Identification of Small Molecule Inhibitors of β-Amyloid Cytotoxicity through a Cell-Based High-Throughput Screening Platform

Department of Pharmacology and Toxicology, University of Kansas, Lawrence, Kansas, Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, Massachusetts, kseyb{at}rics.bwh.harvard.edu

E.R. Schuman

Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, Massachusetts

J. Ni

Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, Massachusetts

M.M. Huang

Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, Massachusetts

M.L. Michaelis

Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, Massachusetts

M.A. Glicksman

Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, Massachusetts

Calpain activation is hypothesized to be an early occurrence in the sequence of events resulting in neurodegeneration, as well as in the signaling pathways linking extracellular accumulation of β-amyloid (Aβ) peptides and intracellular formation of neurofibrillary tangles. In an effort to identify small molecules that prevent neurodegeneration in Alzheimer's disease by early intervention in the cell death cascade, a cell-based assay in differentiated Sh-SY5Y cells was developed using calpain activity as a read-out for the early stages of death in cells exposed to extracellular Aβ. This assay was optimized for high-throughput screening, and a library of approximately 120,000 compounds was tested. It was expected that the compounds identified as calpain inhibitors would include those that act directly on the enzyme and those that prevented calpain activation by blocking an upstream step in the pathway. In fact, of the compounds that inhibited calpain activation by Aβ with IC₅₀ values of <10 µM and showed little or no toxicity at concentrations up to 30 µM, none inhibit the calpain enzyme directly. (Journal of Biomolecular Screening 2008:870-878)

Key Words: β-amyloid • calpain • high-throughput screen • Alzheimer's disease • neurodegeneration

This version was published on October 1, 2008

Journal of Biomolecular Screening, Vol. 13, No. 9, 870-878 (2008)
DOI: 10.1177/1087057108323909


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?